About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT00679796

The Effectiveness of Varicella Vaccination in Children in Germany

This study is undertaken to evaluate the effectiveness of currently licensed varicella vaccines under conditions of routine use in a setting where varicella vaccine is included in the childhood immuni...

Lead sponsor: GlaxoSmithKline•33 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

GlaxoSmithKline

Collaborators

Ludwig-Maximilians - University of Munich

Observational, multicenter, population-based, matched case-control study conducted in selected pediatric practices in the Munich area.

Age

1 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Male or female child at least one year of age, born on or after July 1 2003.
•Residence in Germany
•At least one previous well-child visit to the practice
•Written informed consent obtained from parents/guardians of the subject as per local requirements.
•Specific inclusion criterion for cases:
•Suspected primary varicella disease (i.e. chickenpox) at the time of study entry

Exclusion Criteria

•Ineligible for varicella vaccination, due to any medical contraindication. These contraindications are:
•* History of hypersensitivity to any of the components of the vaccines
•* Congenital or acquired immunodeficiency
•* Treatment with immunosuppressive therapy
•* HIV-infected patients, when CD4 \< 25% of total lymphocytes
•* Previous history of chickenpox by physician record or parental report.
•* Lack of documented vaccination history (written or computerised practice records or child's vaccination card/booklet).

Related studies

RECRUITINGPhase 3

A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years

NCT07054099 · Varicella (Chickenpox), Chickenpox Vaccine

RECRUITINGPhase 3

Second Dose of Varicella Vaccine in Healthy Children

NCT07475000 · Varicella (Chickenpox), Varicella Immunisation

Not Yet RecruitingPhase 4

Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine

NCT06891872 · Varicella (chickenpox), MMR Vaccine, and more

COMPLETEDPhase 3

Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years

NCT06614816 · Chickenpox Vaccines

COMPLETEDPhase 3

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

NCT00226499 · Varicella, Chickenpox Vaccines

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 29, 2012Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment1,012

Start dateFeb 2008

Last updatedOct 29, 2012

Condition

Varicella (Chickenpox)Chickenpox Vaccines

Locations shown

GSK Investigational Site

Baldham, Bavaria

GSK Investigational Site

Deisenhofen, Bavaria

GSK Investigational Site

Freising, Bavaria

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 29, 2012Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions